Come March 28, Vito Imbascani is scheduled to be sworn in as the new chairman of the $12 billion California stem cell agency – an 18-year-old state program to develop revolutionary treatments for such things as brain and blood cancers, heart disease, diabetes, sickle cell disease, spina bifida, incontinence, blindness, arthritis, HIV, stroke, epilepsy and much more.
Employees in an open work space. (Photo: Monkey Business Images, via Shutterstock)OPINION: I recently signed a letter with state Sen. Connie Leyva, chair of the Legislative Women’s Caucus, and six other prominent women in California calling on J.J.Jelincic Jr. to drop out of the race for the CalPERS board after his history of harassing women was revealed by the Sacramento Bee. It matters that three women at CalPERS felt so uncomfortable working with Jelincic that they filed harassment charges against him, and that their allegations were upheld by the California State Personnel Board.